ClinicalTrials.Veeva

Menu
F

Frenova Renal Research | Nephrology and Hypertension Associates, LTD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

VX-147
Povetacicept
Phosphate
Tenapanor
Finerenone
Inaxaplin

Parent organization

This site is a part of Frenova Renal Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Enrolling
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept
Locations recently updated

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

The purpose of the study is to evaluate the efficacy, safety, and tolerability of Inaxaplin (IXP) in participants with proteinuric APOL1- mediated ki...

Enrolling
Proteinuric Kidney Disease
Drug: Inaxaplin

Trial sponsors

Vertex Pharmaceuticals logo
Ardelyx logo
Bayer logo
Celgene logo
P
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems